Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer.

导出 OA

翻译打印收藏纠错

作者： Elgin,Hoffmann ^[1] ; Frank,Paulsen ^[1] ; Philipp,Schaedle ^[1] ; Daniel,Zips ^[2] ; Cihan,Gani ^[3] ; Hans-Georg,Rammensee ^[1] ; Cécile,Gouttefangeas ^[4] ; Franziska,Eckert ^[1]

作者单位： Department of Radiation Oncology, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany. ^[1] Interfaculty Institute for Cell Biology, Department of Immunology, Eberhard-Karls-University Tuebingen, Auf der Morgenstelle 15, 72076, Tuebingen, Germany. ^[2] Department for Internal Medicine I, Marienhospital Stuttgart, Boeheimstr. 37, 70199, Stuttgart, Germany. ^[3] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tuebingen, Tuebingen, Germany. ^[4] Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. ^[5] Department of Radiation Oncology, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany. franziska.eckert@med.uni-tuebingen.de. ^[6] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tuebingen, Tuebingen, Germany. franziska.eckert@med.uni-tuebingen.de. ^[7]

关键词 DVH IMRT Immune status Localized Prostate cancer T cells